Before mediation, the patient was pathologically diagnosed with moderately differentiated squamous cell carcinoma in the lower lobe of the left lung. After surgery, the patient began using CHA for injection alone, without any other anti-tumor drugs. Medication for two and a half years: the patient’s CT examination results showed that there was no obvious abnormality in the operation site and no abnormal hilum and mediastinal lymph nodes. By far, the patient is still on medication, and has no recurrence for 2 years and 11 months after surgery. The patient survives well and enjoys qualify life same as normal healthy people.

Patients with advanced lymphatic metastases in poorly differentiated squamous cell carcinoma of the lung. Shao received clinical trials in 2015 and took continuously the drug. After withdrawal from the study group, the patient continued to use chlorogenic acid for injection alone up to now. The re-examination report dated Feb. 2024 shows that the lung lesions had been completely relieved, and the body conditions are good currently. The lifetime has extended for 10 years.